pimafucort
leo pharma limited - hydrocortisone 1%; natamycin 1%; ; neomycin sulfate 0.35% - topical ointment - active: hydrocortisone 1% natamycin 1% neomycin sulfate 0.35% excipient: liquid paraffin polyethylene
predmycin-p
allergan new zealand ltd - neomycin sulfate 0.5%; polymyxin b sulfate 5000 u/ml; prednisolone acetate 0.5% - eye drops, solution - active: neomycin sulfate 0.5% polymyxin b sulfate 5000 u/ml prednisolone acetate 0.5%
rogaine
johnson & johnson (new zealand) limited - minoxidil 2%{relative}; - topical gel - 2% w/w - active: minoxidil 2%{relative} excipient: carbomer diisopropanolamine ethanol propylene glycol purified water
rogaine (women's)
johnson & johnson (new zealand) limited - minoxidil 20 mg/ml; - topical solution - 2 % - active: minoxidil 20 mg/ml excipient: ethanol propylene glycol purified water
lyrica
upjohn eesv - pregabalin - epilepsy; anxiety disorders; neuralgia - antiepileptics, , other antiepileptics - neuropathic painlyrica is indicated for the treatment of peripheral and central neuropathic pain in adults.epilepsylyrica is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.generalised anxiety disorderlyrica is indicated for the treatment of generalised anxiety disorder (gad) in adults.
pregabalin pfizer
upjohn eesv - pregabalin - anxiety disorders; epilepsy - antiepileptics, - neuropathic painpregabalin pfizer is indicated for the treatment of peripheral and central neuropathic pain in adults.epilepsypregabalin pfizer is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.generalised anxiety disorderpregabalin pfizer is indicated for the treatment of generalised anxiety disorder (gad) in adults.
revatio
upjohn eesv - sildenafil - hypertension, pulmonary - urologicals - treatment of adult patients with pulmonary arterial hypertension classified as world health organization (who) functional class ii and iii, to improve exercise capacity. efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease.paediatric populationtreatment of paediatric patients aged one year to 17 years old with pulmonary arterial hypertension. efficacy in terms of improvement of exercise capacity or pulmonary haemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease.revatio solution for injection is for the treatment of adult patients with pulmonary arterial hypertension who are currently prescribed oral revatio and who are temporarily unable to take oral therapy, but are otherwise clinically and haemodynamically stable.revatio (oral) is indicated for treatment of adult patients with pulmonary arterial hypertension classified as who functional class ii and iii, to improve exercise capacity. efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease.
atorvastatin 80mg tablets
upjohn uk ltd - atorvastatin calcium trihydrate - oral tablet - 80mg
santizor xl 4mg capsules
upjohn uk ltd - tolterodine tartrate - modified-release capsule - 4mg
celecoxib 100mg capsules
upjohn uk ltd - celecoxib - oral capsule - 100mg